Clinical Trials
306 trialsTesting of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
Liquid Biopsy Multi-Omics and Biomarker Development in Melanoma
Xijing Hospital
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
LONGEVITI
University of Alberta
SHERLOCK
University Health Network, Toronto
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
University Health Network, Toronto
iCaRe2
University of Nebraska
Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
M.D. Anderson Cancer Center
TUPRO
University of Zurich
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care
Dana-Farber Cancer Institute
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
ctDNA for Early Detection of Recurrence in Melanoma
Herlev and Gentofte Hospital
CER
Cancer Support Community, Research and Training Institute, Philadelphia
SJFAMILY
St. Jude Children's Research Hospital
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
M.D. Anderson Cancer Center
HELIOPREDICT
Nantes University Hospital
ctDNA for Risk Stratification in Melanoma
Herlev and Gentofte Hospital
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
University of California, San Francisco
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The Christie NHS Foundation Trust
COSMIC
Wake Forest University Health Sciences
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Ohio State University
Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma
Mayo Clinic
IMMUMELA
Assistance Publique - Hôpitaux de Paris
Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma
Institute of Oncology Ljubljana
PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
Peking University Cancer Hospital & Institute
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
M.D. Anderson Cancer Center
Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center
FIBIOME
University Hospital, Grenoble
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
A Study of Tumor Imaging With Multispectral Optoacoustic Tomography
Memorial Sloan Kettering Cancer Center
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
Ohio State University Comprehensive Cancer Center
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
University of Oklahoma
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
Mayo Clinic
EVpredict
Centre Georges Francois Leclerc
Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma
University of Wisconsin, Madison
IMPACT
Peter MacCallum Cancer Centre, Australia
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
University of Pittsburgh
COPERGRAM1
Nantes University Hospital
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
University of Wisconsin, Madison
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
Memorial Sloan Kettering Cancer Center
SPECIAL
University Health Network, Toronto
Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection
Memorial Sloan Kettering Cancer Center
ICI-PICK
Indiana University
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
Mayo Clinic
IMM
University Hospital, Strasbourg, France
MELA_2025
Ente Ospedaliero Ospedali Galliera
ROTATE
The Christie NHS Foundation Trust
Mesur
University of Modena and Reggio Emilia